| 摘要 |
<p><P>PROBLEM TO BE SOLVED: To provide the use of a hypoglycemic agent or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the prevention or delay of the progression to overt diabetes, especially type 2, prevention or reduction of microvascular complications (eg, retinopathy, neuropathy, nephropathy), prevention or reduction of excessive cardiovascular morbidity (eg, myocardial infarction, arterial occlusive disease, atherosclerosis and stroke) and cardiovascular mortality, prevention of cancer and reduction of cancer deaths. <P>SOLUTION: In order to solve the problem, this invention uses a hypoglycemic agent or its medicinally acceptable salt. Further, this invention relate to the use for treating the diseases and the symptom relating to IGM, ITM or IFG. <P>COPYRIGHT: (C)2007,JPO&INPIT</p> |
